Home LiteratureArticle Details
PMID: 12084879 Published · ppublish English Comparative Study Journal Article Research Support, Non-U.S. Gov't

Phases of A beta-deposition in the human brain and its relevance for the development of AD.

Neurology ·Vol. 58 ·No. 12 ·2002-06-25 ·Pages 1791-800

Thal DR, Rüb U, Orantes M, Braak H

Abstract

The deposition of the amyloid beta protein (Abeta) is a histopathologic hallmark of AD. The regions of the medial temporal lobe (MTL) are hierarchically involved in Abeta-deposition. To clarify whether there is a hierarchical involvement of the regions of the entire brain as well and whether there are differences in the expansion of Abeta-pathology between clinically proven AD cases and nondemented cases with AD-related pathology, the authors investigated 47 brains from demented and nondemented patients with AD-related pathology covering all phases of beta-amyloidosis in the MTL (AbetaMTL phases) and four control brains without any AD-related pathology. Abeta deposits were detected by the use of the Campbell-Switzer silver technique and by immunohistochemistry in sections covering all brain regions and brainstem nuclei. It was analyzed how often distinct regions exhibited Abeta deposits. In the first of five phases in the evolution of beta-amyloidosis Abeta deposits are found exclusively in the neocortex. The second phase is characterized by the additional involvement of allocortical brain regions. In phase 3, diencephalic nuclei, the striatum, and the cholinergic nuclei of the basal forebrain exhibit Abeta deposits as well. Several brainstem nuclei become additionally involved in phase 4. Phase 5, finally, is characterized by cerebellar Abeta-deposition. The 17 clinically proven AD cases exhibit Abeta-phases 3, 4, or 5. The nine nondemented cases with AD-related Abeta pathology show Abeta-phases 1, 2, or 3. Abeta-deposition in the entire brain follows a distinct sequence in which the regions are hierarchically involved. Abeta-deposition, thereby, expands anterogradely into regions that receive neuronal projections from regions already exhibiting Abeta. There are also indications that clinically proven AD cases with full-blown beta-amyloidosis may be preceded in early stages by nondemented cases exhibiting AD-related Abeta pathology.

MeSH Terms
Adult Aged Aged, 80 and over Alzheimer Disease/etiology,metabolism,pathology Amyloid beta-Peptides/biosynthesis,metabolism Brain/metabolism,pathology Female Humans Male Middle Aged Models, Neurological Statistics, Nonparametric
Chemicals
Amyloid beta-Peptides
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Thal Dietmar R
Department of Anatomy, J. W. Goethe University, Frankfurt am Main, Germany. Dietmar.Thal@uni-bonn.de
Rüb Udo
Orantes Mario
Braak Heiko
Article Info
Journal
Neurology
Abbr.
Neurology
ISSN
0028-3878
Published
2002-06-25
Pages
1791-800
Language
English
Region
United States
NLM ID
0401060
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com